Antimicrobial peptides for combating drug-resistant bacterial infections.

Jiaqi Xuan, Weiguo Feng, Jiaye Wang, Ruichen Wang, Bowen Zhang, Letao Bo, Zhe-Sheng Chen, Hui Yang, Leming Sun
Author Information
  1. Jiaqi Xuan: School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China; Innovation Center NPU Chongqing, Northwestern Polytechnical University, Chongqing 400000, China.
  2. Weiguo Feng: School of Life Science and Technology, Weifang Medical University, Weifang 261053, Shandong, China.
  3. Jiaye Wang: School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China.
  4. Ruichen Wang: School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China.
  5. Bowen Zhang: School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China.
  6. Letao Bo: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
  7. Zhe-Sheng Chen: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address: chenz@stjohns.edu.
  8. Hui Yang: School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China. Electronic address: kittyyh@nwpu.edu.cn.
  9. Leming Sun: School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China; Innovation Center NPU Chongqing, Northwestern Polytechnical University, Chongqing 400000, China. Electronic address: lmsun@nwpu.edu.cn.

Abstract

The problem of drug resistance due to long-term use of antibiotics has been a concern for years. As this problem grows worse, infections caused by multiple bacteria are expanding rapidly and are extremely detrimental to human health. Antimicrobial peptides (AMPs) are a good alternative to current antimicrobials with potent antimicrobial activity and unique antimicrobial mechanisms, which have advantages over traditional antibiotics in fighting against drug-resistant bacterial infections. Currently, researchers have conducted clinical investigations on AMPs for drug-resistant bacterial infections while integrating new technologies in the development of AMPs, such as changing amino acid structure of AMPs and using different delivery methods for AMPs. This article introduces the basic properties of AMPs, deliberates the mechanism of drug resistance in bacteria and the therapeutic mechanism of AMPs. The current disadvantages and advances of AMPs in combating drug-resistant bacterial infections are also discussed. This article provides important insights into the research and clinical application of new AMPs for drug-resistant bacterial infections.

Keywords

MeSH Term

Humans
Antimicrobial Peptides
Antimicrobial Cationic Peptides
Bacterial Infections
Anti-Infective Agents
Anti-Bacterial Agents
Bacteria

Chemicals

Antimicrobial Peptides
Antimicrobial Cationic Peptides
Anti-Infective Agents
Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0AMPsinfectionsdrug-resistantbacterialresistanceAntimicrobialpeptidesproblemdrugantibioticsbacteriacurrentantimicrobialclinicalnewarticlemechanismcombatingduelong-termuseconcernyearsgrowsworsecausedmultipleexpandingrapidlyextremelydetrimentalhumanhealthgoodalternativeantimicrobialspotentactivityuniquemechanismsadvantagestraditionalfightingCurrentlyresearchersconductedinvestigationsintegratingtechnologiesdevelopmentchangingaminoacidstructureusingdifferentdeliverymethodsintroducesbasicpropertiesdeliberatestherapeuticdisadvantagesadvancesalsodiscussedprovidesimportantinsightsresearchapplicationAntibioticsBacterialinfectionDrug

Similar Articles

Cited By